CurvaFix released real world numbers on its first 3,800 pelvic implants. More than 200 surgeons placed them. The removal rate was 1.45 percent.

Breakage in vivo came in at 0.03 percent, implant backout at 0.05 percent and malpositioning at 0.24 percent. Surgeons present the data at the Orthopaedic Trauma Association annual meeting in Nashville, which runs September 23 to 26. Seven published articles cover the technology in fragility fractures, trauma and oncology cases.

The company sells two 510(k) cleared systems from Kirkland, Washington: the CurvaFix IM System and a Low Profile System introduced at OTA 2025 with a head 65 percent smaller. A registry style count carries less weight than a controlled trial. For an implant company still building surgeon trust it is also the cheapest credible evidence available.